Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

South Korea preps coronavirus vaccines after political scuffle over first shots

Published 02/25/2021, 12:36 AM
Updated 02/25/2021, 12:40 AM
© Reuters. A nurse takes part in the coronavirus disease (COVID-19) vaccination mock drill at the COVID-19 vaccination center in Seoul

By Sangmi Cha and Josh Smith

SEOUL (Reuters) - South Korean politicians won't be the first in line when the county kicks off its coronavirus vaccination drive on Friday, despite calls from the opposition party for the president to roll up his sleeve and take a shot to reassure vaccine sceptics.

Leading political figures spent the week trading rhetorical shots over who should be the first to take a literal jab, but in the end, health authorities said widespread acceptance of vaccines in South Korea means they would stick to plans to vaccinate healthcare workers and other at-risk individuals first.

On Thursday, the first doses of AstraZeneca (NASDAQ:AZN)'s coronavirus vaccine were distributed to clinics in preparation for the initial inoculations.

Prime Minister Chung Sye-kyun decried the debate over whether President Moon Jae-in should be first up, writing on Facebook (NASDAQ:FB) that "vaccination should not be an instrument of political strife."

On Thursday he pleaded for trust in government and called for active participation from the public.

"Reaching herd immunity is nothing more than an illusion if the people distrust the vaccines and avoid receiving the shots," Chung told a government meeting.

Government surveys have shown more than 90% of those eligible want to be vaccinated.

However, AstraZeneca's product faced scrutiny after health regulators decided not to offer it to people 65 and over until more efficacy data is available.

While there is no evidence of safety risk from the vaccine, some members of the conservative opposition party criticised Moon for not being the first to be inoculated as a way to reassure citizens.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Moon, along with other politicians from both sides, had said he would be willing to be the first vaccinated. His office later said the president would wait his turn, given the lack of major concerns about vaccinations among the public.

Last week former opposition party lawmaker Yoo Seong-min urged Moon on social media to take the shot first as a way to eliminate distrust.

A member of Moon's party fired back, arguing the head of state is not an experimental subject.

"This is a mockery and insult against a nation's leader," ruling party lawmaker Jung Chung-rae wrote on Facebook.

Korea Disease Control and Prevention Agency (KDCA) director Jeong Eun-kyeong told a briefing on Wednesday it would be inappropriate to consider anyone getting a vaccine now as a subject in an experiment, given the proven results.

Preliminary study findings in Scotland, for example, show that country's vaccine drive appears to be markedly reducing the risk of hospitalisation for COVID-19, suggesting both the Pfizer-BioNTech and Oxford-AstraZeneca shots are highly effective in preventing severe infections.

Latest comments

Acting carrefully with Covax vaccines is a neccessity because it are vaccines who could no longer be sold at normal price. I recommand only one shot for the use at this moment in time and waiting for the results of other tests with a combination of russian vaccine for the seconde shot later. The news for this is available on internet. So, don't act too rapidely.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.